In vitro growth and analysis of candida biofilms

Nature Protocols

Volumn 3, Issue 12, 2008, Pages 1909-1924

  Chandra, Jyotsna ^a   Mukherjee, Pranab K ^a   Ghannoum, Mahmoud A ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT;

APPARATUS, EQUIPMENT AND SUPPLIES; ARTICLE; BIOFILM; CANDIDA; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; MICROBIOLOGY; PHYSIOLOGY;

ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA; EQUIPMENT AND SUPPLIES;

EID: 63349084704     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2008.192     Document Type: Article

References (27)

1. Donlan, R.M.: Biofilms and device-associated infections. Emerg. Infect. Dis. 7, 277-281 (2001).
2. Kuhn, D.M. and Ghannoum, M.A.: Candida biofilms: antifungal resistance and emerging therapeutic options. Curr. Opin. Investig. Drugs 5, 186-197 (2004).
3. Douglas, L.J.: Candida biofilms and their role in infection. Trends Microbiol. 11, 30-36 (2003).
4. Donlan, R.M. and Costerton, J.W.: Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15, 167-193 (2002).
5. Imamura, Y.: Fusarium and Candida albicans biofilmsonsoft contact lenses: model development, influence of lens type and susceptibility to lens care solutions. Antimicrob. Agents Chemother. 52, 171-182 (2008).
6. Nett, J. and Andes, D.: Candida albicans biofilm development, modeling a host-pathogen interaction. Curr. Opin. Microbiol. 9, 340-345 (2006).
7. Hawser, S.P. and Douglas, L.J.: Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect. Immun. 62, 915-921 (1994).
8. Chandra, J.: Biofilm formation by the fungal pathogen Candida albicans— development, architecture and drug resistance. J. Bacteriol. 183, 5385-5394 (2001).
9. Chandra, J.: Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. J. Dent. Res. 80, 903-908 (2001).
10. Peeters, E., Nelis, H.J. and Coenye, T.: Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates. J. Microbiol. Methods 72, 157-165 (2008).
11. Valentin, A., Canton, E., Peman, J. and Quindos, G.: In vitro activity ofamphotericin B and anidulafungin against Candida spp. biofilms. Rev. Iberoam. Micol. 24, 272-277 (2007).
12. Tsang, C., Ng, H. and McMillan, A.: Antifungal susceptibility of Candida albicans biofilms on titanium discs with differentsurface roughness. Clin. Oral Invest. 11, 361-368 (2007).
13. Ramage, G., Wickes, B. and Lopez-Ribot, J.: Inhibition on Candida albicans biofilm formation using divalent cation chelators (EDTA). Mycopathologia 164, 301-306 (2007).
14. Jin, Y., Yip, H.K., Samaranayake, Y.H., Yau, J.Y. and Samaranayake, L.P.: Biofilmforming ability of Candida albicans is unlikely to contribute to high levels of oral yeast carriage in cases of human immunodeficiency virus infection. J. Clin. Microbiol. 41, 2961-2967 (2003).
15. Mowat, E., Butcher, J., Lang, S., Williams, C. and Ramage, G.: Development of a simple model for studying the effects of antifungal agents on multicellular communities of Aspergillus fumigatus. J. Med. Microbiol. 56, 1205-1212 (2007).
16. Martinez, L.R. and Casadevall, A.: Cryptococcus neoformans biofilm formation depends on surface support and carbon source and reduces fungal cell susceptibility to heat, cold, and UV light. Appl. Environ. Microbiol. 73, 4592-4601 (2007).
17. Kuhn, D.M., Chandra, J., Mukherjee, P.K. and Ghannoum, M.A.: Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect. Immun. 70, 878-888 (2002).
18. Chandra, J.: Modification ofsurface properties of biomaterials influences the ability of C. albicans to form biofilms. Appl. Environ. Microbiol. 71, 8795-8801 (2005).
19. Raad, I.: In vitro and ex vivo activities of minocycline and EDTA against microorganisms embedded in biofilm on catheter surfaces. Antimicrob. Agents Chemother. 47, 3580-3585 (2003).
20. Percival, S.L.: Tetrasodium EDTA as a novel central venous catheter lock solution against biofilm. Infec. Ctrl. Hosp. Epidemiol. 26, 515-519 (2005).
21. Walker, J.T.: Microbial biofilm formation and contamination of dental-unit watersystems in general dental practice. Appl. Environ. Microbiol. 66, 3363-3367 (2000).
22. Shah, C.B.: Antimicrobial activity of a novel catheter lock solution. Antimicrob. Agents Chemother. 46, 1674-1679 (2002).
23. Lewis, R.E., Kontoyiannis, D.P., Darouiche, R.O., Raad, I.I. and Prince, R.A.: Antifungal activity ofamphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection. Antimicrob. Agents Chemother. 46, 3499-3505 (2002).
24. Kuhn, D.M.: Candida parapsilosis characterization in an outbreak setting. Emerg. Infect. Dis. 10, 1074-1081 (2004).
25. Marr, K.A., Rustad, T.R., Rex, J.H. and White, T.C.: The trailing end point phenotype in antifungal susceptibility testing is pH dependent. Antimicrob. Agents Chemother. 43, 1383-1386 (1999).
26. Wiederhold, N.P.: Attenuation of echinocandin activity at elevated concentrations: a review of the paradoxical effect. Curr. Opin. Infect. Dis. 20, 574-578 (2007).
27. Kuhn, D.M., George, T., Chandra, J., Mukherjee, P.K. and Ghannoum, M.A.: Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob. Agents Chemother. 46, 1773-1780 (2002)